Mycotopia Financial Statements From 2010 to 2026

TPIADelisted Stock  USD 0.02  0  14.29%   
Mycotopia Therapies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mycotopia Therapies' valuation are provided below:
Mycotopia Therapies does not presently have any fundamental ratios for analysis.
Check Mycotopia Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mycotopia Therapies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Mycotopia financial statements analysis is a perfect complement when working with Mycotopia Therapies Valuation or Volatility modules.
  
This module can also supplement various Mycotopia Therapies Technical models . Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Mycotopia Therapies Company Return On Equity Analysis

Mycotopia Therapies' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Mycotopia Therapies Return On Equity

    
  -58.61  
Most of Mycotopia Therapies' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mycotopia Therapies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Mycotopia Therapies has a Return On Equity of -58.6088. This is 144.51% higher than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The return on equity for all United States stocks is notably higher than that of the company.

Mycotopia Therapies Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mycotopia Therapies's current stock value. Our valuation model uses many indicators to compare Mycotopia Therapies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mycotopia Therapies competition to find correlations between indicators driving Mycotopia Therapies's intrinsic value. More Info.
Mycotopia Therapies is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Mycotopia Therapies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mycotopia Therapies' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Mycotopia Therapies Financial Statements

Mycotopia Therapies stakeholders use historical fundamental indicators, such as Mycotopia Therapies' revenue or net income, to determine how well the company is positioned to perform in the future. Although Mycotopia Therapies investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mycotopia Therapies' assets and liabilities are reflected in the revenues and expenses on Mycotopia Therapies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mycotopia Therapies. Please read more on our technical analysis and fundamental analysis pages.
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, severe anxiety, depression, palliative care, and serotonin syndrome. Mycotopia Therapies operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Mycotopia Pink Sheet

If you are still planning to invest in Mycotopia Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mycotopia Therapies' history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges